Kathmere Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
24,979
+3,149
| +14% | +$349K | 0.21% | 88 |
|
|
2025
Q1 | $2.45M | Buy |
21,830
+4,303
| +25% | +$482K | 0.21% | 82 |
|
|
2024
Q4 | $1.62M | Buy |
17,527
+5,246
| +43% | +$485K | 0.15% | 96 |
|
|
2024
Q3 | $1.03M | Buy |
12,281
+2,266
| +23% | +$190K | 0.1% | 127 |
|
|
2024
Q2 | $687K | Buy |
10,015
+7,051
| +238% | +$484K | 0.07% | 145 |
|
|
2024
Q1 | $217K | Buy |
2,964
+460
| +18% | +$33.7K | 0.02% | 298 |
|
|
2023
Q4 | $203K | Buy |
+2,504
| New | +$203K | 0.03% | 277 |
|
|
2023
Q2 | – | Sell |
-2,776
| Closed | -$230K | – | 243 |
|
|
2023
Q1 | $230K | Buy |
+2,776
| New | +$230K | 0.04% | 181 |
|